Navigation Links
Sigma-Aldrich (Nasdaq: SIAL) CAO & CFO Hogan Plans to Retire; Search for Successor Underway

ST. LOUIS, May 14 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) announced today that Chief Administrative Officer and Chief Financial Officer Michael R. Hogan will retire at a date to be determined this summer. Hogan, who turned 55 in April, had notified the Company early this year of his desire to retire as soon as his successor could be identified and successfully transitioned. The Company has initiated a search to identify a successor from a pool of internal and external candidates.

Following his retirement, Hogan will continue to assist with the Company's charitable giving activities as an unpaid Vice President and outside Director of the independent Sigma-Aldrich Foundation, which he co-founded with Chairman David R. Harvey in 2004.

"From the day I joined Sigma-Aldrich, I've been very open about my dream to devote full-time energy to volunteer civic and charitable work after reaching early retirement age," Hogan said. "Sigma-Aldrich's tremendous success over the past nine years has empowered me to pursue that dream. I look forward to rooting from the sidelines as one of the Company's biggest fans."

Company Chairman David Harvey said, "We express our sincere thanks and gratitude to Mike for his dedication, professionalism, and his untiring efforts on behalf of Sigma-Aldrich."

"Sigma-Aldrich is losing a valuable member of our executive team," said President & CEO Jai Nagarkatti. "But I am happy for Mike that he'll be able to spend more of his time on the many charitable endeavors for which he is known. Though we fully appreciate his decision to step back from active management, we'll miss his strategic leadership, good judgment and sense of humor."

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 36 countries and has 7,900 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich Recognized by BioInformatics, LLC as Having the Most Useful and Easiest to Use Online and Print Catalogs
2. Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries
3. Sigma-Aldrich to Present at the Baird 2008 Growth Stock Conference on Tuesday, May 13, 2008
4. Sigma-Aldrich to Present at the Bank of America 2008 Healthcare Conference on Tuesday, May 13, 2008
5. Sigma-Aldrich Announces the Integration of Riedel-De Haen Into Core Product Brands
6. Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%.
7. Sigma-Aldrich Corporation 1st Quarter 2008 Earnings Conference Call
8. Sigma-Aldrich Partners With Sunset Molecular Discovery to Expand Your Favorite Gene Search Tool
9. Sigma-Aldrich To Hold Annual Business Review
10. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
11. Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies
Post Your Comments:
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... , ... October 10, 2017 , ... Dr. Bob Harman, ... his local San Diego Rotary Club. The event entitled “Stem Cells ... and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):